A
Azra C. Ghani
Researcher at Imperial College London
Publications - 325
Citations - 35805
Azra C. Ghani is an academic researcher from Imperial College London. The author has contributed to research in topics: Population & Malaria. The author has an hindex of 77, co-authored 304 publications receiving 29057 citations. Previous affiliations of Azra C. Ghani include Wellcome Trust & World Health Organization.
Papers
More filters
Journal ArticleDOI
Estimates of the severity of coronavirus disease 2019: a model-based analysis.
Robert Verity,Lucy C Okell,Ilaria Dorigatti,Peter Winskill,Charles Whittaker,Natsuko Imai,Gina Cuomo-Dannenburg,Hayley A Thompson,Patrick G T Walker,Han Fu,Amy Dighe,Jamie T. Griffin,Marc Baguelin,Sangeeta N. Bhatia,A Boonyasiri,Anne Cori,Zulma M. Cucunubá,Richard G. FitzJohn,Katy A. M. Gaythorpe,W Green,Arran Hamlet,Wes Hinsley,Daniel J Laydon,Gemma Nedjati-Gilani,Steven Riley,Sabine L. van Elsland,Erik M. Volz,Haowei Wang,Y Wang,Xiaoyue Xi,Christl A. Donnelly,Christl A. Donnelly,Azra C. Ghani,Neil M. Ferguson +33 more
TL;DR: These early estimates give an indication of the fatality ratio across the spectrum of COVID-19 disease and show a strong age gradient in risk of death.
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand
Neil M. Ferguson,Daniel J Laydon,G Nedjati Gilani,Natsuko Imai,Kylie E. C. Ainslie,Marc Baguelin,Sangeeta N. Bhatia,A Boonyasiri,Z Cucunuba Perez,Gina Cuomo-Dannenburg,Amy Dighe,Ilaria Dorigatti,Han Fu,Katy A. M. Gaythorpe,W Green,Arran Hamlet,Wes Hinsley,Lucy C Okell,S Van Elsland,H Thompson,Robert Verity,Erik M. Volz,Haowei Wang,Y Wang,Patrick G T Walker,Caroline E. Walters,Peter Winskill,Charles Whittaker,Christl A. Donnelly,Steven Riley,Azra C. Ghani +30 more
TL;DR: Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell.
Journal ArticleDOI
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.
Seth Flaxman,Swapnil Mishra,Axel Gandy,H. Juliette T. Unwin,Thomas A. Mellan,Helen Coupland,Charles Whittaker,Harrison Zhu,Tresnia Berah,Jeffrey W. Eaton,Melodie Monod,Azra C. Ghani,Christl A. Donnelly,Christl A. Donnelly,Steven Riley,Michaela A. C. Vollmer,Neil M. Ferguson,Lucy C Okell,Samir Bhatt +18 more
TL;DR: The results show that major non-pharmaceutical interventions and lockdown in particular have had a large effect on reducing transmission and continued intervention should be considered to keep transmission of SARS-CoV-2 under control.
Journal ArticleDOI
Pandemic Potential of a Strain of Influenza A (H1N1) : Early Findings
Christophe Fraser,Christl A. Donnelly,Simon Cauchemez,William P. Hanage,Maria D. Van Kerkhove,T. Déirdre Hollingsworth,Jamie T. Griffin,Rebecca F. Baggaley,Helen E. Jenkins,Emily J. Lyons,Thibaut Jombart,Wes Hinsley,Nicholas C. Grassly,Francois Balloux,Azra C. Ghani,Neil M. Ferguson,Andrew Rambaut,Oliver G. Pybus,Hugo López-Gatell,Celia Alpuche-Aranda,Ietza Bojorquez Chapela,Ethel Palacios Zavala,Dulce Ma. Espejo Guevara,Francesco Checchi,Erika Garcia,Stéphane Hugonnet,Cathy Roth +26 more
TL;DR: Transmissibility is substantially higher than that of seasonal flu, and comparable with lower estimates of R0 obtained from previous influenza pandemics, by analyzing the outbreak in Mexico, early data on international spread, and viral genetic diversity, which makes an early assessment of transmissibility and severity.
Journal ArticleDOI
Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions.
Steven Riley,Christophe Fraser,Christl A. Donnelly,Azra C. Ghani,Laith J. Abu-Raddad,Anthony J. Hedley,Gabriel M. Leung,Lai-Ming Ho,Tai Hing Lam,TQ Thach,Patsy Chau,King Pan Chan,Su Vui Lo,Pak Yin Leung,Thomas Tsang,William Ho,Koon Hung Lee,Edith M. C. Lau,Neil M. Ferguson,Roy M. Anderson +19 more
TL;DR: Transmission rates fell during the SARS epidemic, primarily as a result of reductions in population contact rates and improved hospital infection control, but also because of more rapid hospital attendance by symptomatic individuals.